2024 - RAS Dialogue Blog
-
Development of Mutant KRAS Molecuar Target Drugs and Future Prospects: Report
In a new post, Drs. Fuyuhiko Tamanoi, Hideyuki Saya, Toshio Imai, and Kiyoko Kato present a report of the online meeting that they organized, titled “Development of mutant KRAS molecular target drugs and future prospects.”
-
Senescent macrophages promote oncogenic KRAS-driven lung cancer and suppress anti-tumour immunity
Drs. Haston, Muñoz-Espin, and Martinez-Barbera describe their work uncovering the important role that senescent macrophages play in promoting KRAS-driven lung cancers.